Such results may raise questions epitomizing the fact that facial musculature impairment, as an initial symptom of FSHD, is closely correlated to changes in DUX4 expression levels more than different muscle groups. The gene discussed is DUX4; the disease is facioscapulohumeral muscular dystrophy.